BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18362281)

  • 1. Dementia and survival in Parkinson disease: a 12-year population study.
    Buter TC; van den Hout A; Matthews FE; Larsen JP; Brayne C; Aarsland D
    Neurology; 2008 Mar; 70(13):1017-22. PubMed ID: 18362281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.
    Aarsland D; Andersen K; Larsen JP; Lolk A; Kragh-Sørensen P
    Arch Neurol; 2003 Mar; 60(3):387-92. PubMed ID: 12633150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of dementia in Parkinson's disease: a community-based, prospective study.
    Aarsland D; Andersen K; Larsen JP; Lolk A; Nielsen H; Kragh-Sørensen P
    Neurology; 2001 Mar; 56(6):730-6. PubMed ID: 11274306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of dementia in Parkinson disease.
    Aarsland D; Tandberg E; Larsen JP; Cummings JL
    Arch Neurol; 1996 Jun; 53(6):538-42. PubMed ID: 8660156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Projections of prevalence, lifetime risk, and life expectancy of Parkinson's disease (2010-2030) in France.
    Wanneveich M; Moisan F; Jacqmin-Gadda H; Elbaz A; Joly P
    Mov Disord; 2018 Sep; 33(9):1449-1455. PubMed ID: 30145805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What predicts mortality in Parkinson disease?: a prospective population-based long-term study.
    Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
    Neurology; 2010 Oct; 75(14):1270-6. PubMed ID: 20921512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    JAMA Neurol; 2013 May; 70(5):580-6. PubMed ID: 23529397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease.
    Hughes TA; Ross HF; Musa S; Bhattacherjee S; Nathan RN; Mindham RH; Spokes EG
    Neurology; 2000 Apr; 54(8):1596-602. PubMed ID: 10762499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study.
    Riedel O; Heuser I; Klotsche J; Dodel R; Wittchen HU;
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):27-34. PubMed ID: 20042544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of incident dementia with mortality in PD.
    Levy G; Tang MX; Louis ED; Côté LJ; Alfaro B; Mejia H; Stern Y; Marder K
    Neurology; 2002 Dec; 59(11):1708-13. PubMed ID: 12473757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of dementia in an elderly population of Parkinson's disease patients: a 15-year population-based study.
    Perez F; Helmer C; Foubert-Samier A; Auriacombe S; Dartigues JF; Tison F
    Alzheimers Dement; 2012 Nov; 8(6):463-9. PubMed ID: 22651942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom.
    Hobson P; Meara J
    Mov Disord; 2004 Sep; 19(9):1043-9. PubMed ID: 15372593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor impairment in PD: relationship to incident dementia and age.
    Levy G; Tang MX; Cote LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Neurology; 2000 Aug; 55(4):539-44. PubMed ID: 10953188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of survival in patients with Parkinson disease.
    Willis AW; Schootman M; Kung N; Evanoff BA; Perlmutter JS; Racette BA
    Arch Neurol; 2012 May; 69(5):601-7. PubMed ID: 22213411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    Neurology; 2017 Feb; 88(8):767-774. PubMed ID: 28108638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dementia-free life expectancy among elderly Japanese.
    Sauvaget C; Tsuji I; Minami Y; Fukao A; Hisamichi S; Asano H; Sato M
    Gerontology; 1997; 43(3):168-75. PubMed ID: 9142511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating dementia-free life expectancy for Parkinson's patients using Bayesian inference and microsimulation.
    van den Hout A; Matthews FE
    Biostatistics; 2009 Oct; 10(4):729-43. PubMed ID: 19648228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The estimated life expectancy in a community cohort of Parkinson's disease patients with and without dementia, compared with the UK population.
    Hobson P; Meara J; Ishihara-Paul L
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1093-8. PubMed ID: 20571039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical milestones in Parkinson's disease: A 7-year population-based incident cohort study.
    Bjornestad A; Pedersen KF; Tysnes OB; Alves G
    Parkinsonism Relat Disord; 2017 Sep; 42():28-33. PubMed ID: 28578818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study.
    de Lau LM; Schipper CM; Hofman A; Koudstaal PJ; Breteler MM
    Arch Neurol; 2005 Aug; 62(8):1265-9. PubMed ID: 16087767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.